World Parkinson Congress Blog

Early Career Scientists Adapt to Working Remotely by Taking Science Virtual

by Drs. Johnson and Bergkvist

Clinical ScienceDrs. Johnson and BergkvistJune 15, 2020Parkinson's, webinar, postdoc, scientists, fiveComment

Flow vs. Freeze: The Healing Power of Taiko

by Sydney Shiroyama & Barbara Rice

Clinical ScienceSydney Shiroyama & Barbara RiceJune 8, 2020Kyoto, Parkinson's, physical therapy, fiveComment

Using Stem Cells to Understand Parkinson's Disease

by Alexander Laperle, PhD

Clinical ScienceAlexander Laperle, PhDJune 1, 2020Parkinson's, Kyoto, Stem CellsComment

Creating a Virtuous Cycle of PwP Support

by Dr Alison Williams, Judith Shepherd and Bill Wright

Nurse-led Research Supports the Establishment of Specialist Parkinson’s Nurse Positions in Australia

by Rachel Rossiter

Clinical ScienceRachel RossiterMay 18, 2020Parkinson's, Kyoto, NursingComment

Are Neuropsychiatric Symptoms an Early Sign of Parkinson’s?

by Alexandru Hanganu, Ph.D.

Clinical ScienceAlexandru Hanganu, PhDMay 11, 2020Symptoms, anxiety, Parkinson's, Depression, fiveComment

Beyond Dopamine: The Role of Glutamate in Parkinson’s Disease

by Naila Kuhlmann, PhD

Clinical ScienceNaila Kuhlmann, PhDMay 4, 2020Dopamine, Parkinson's, Kyoto, World Parkinson Congress, fiveComment

Parkinson’s disease: Three Steps to Maintaining Intimacy During the Coronavirus - Part III

by Gila Bronner, MPH, MSW

Clinical ScienceGila Bronner MPH, MSWApril 29, 2020Parkinson's, Intimacy, corona virus, fiveComment

Shed Light on Dopamine D2 Receptors and Dyskinesia

by Laura Andreoli, PhD Candidate

Clinical ScienceLaura Andreoli, PhD CandidateApril 27, 2020Parkinson's, Dyskinesia, Dopamine, Kyoto, fiveComment

Parkinson’s Disease: Three Steps to Maintaining Intimacy During the Coronavirus - Part II

by Gila Bronner, MPH, MSW

Clinical ScienceGila Bronner MPH, MSWApril 22, 2020corona virus, Parkinson's, Intimacy, fiveComment

Keep Calm and Research On

by Xi Chen, PhD

Clinical ScienceXi Chen, PhDApril 20, 2020parkinsons, Kyoto, World Parkinson Congress, neurodegeneration, fiveComment

Parkinson’s Disease: Three Steps to Maintaining Intimacy During the Coronavirus - Part I

by Gila Bronner, MPH, MSW

Clinical ScienceGila Bronner MPH, MSWApril 15, 2020Parkinson's, Intimacy, fiveComment

The Ultimate Goal: Finding an Etiologically Relevant, Disease-Modifying Therapy for Parkinson´s Disease

by Mattia Volta, PhD

Clinical ScienceMattia Volta, PhDApril 13, 2020Parkinson's, Disease Modification, fiveComment

Thinking Outside the Box: Beyond the Conventional Effects of Alpha-Synuclein

by Tiago Fleming Outeiro, PhD

Clinical ScienceTiago Fleming Outiero, PhDApril 6, 2020Parkinson's, Protein, fourComment

The Promise of New Technologies in Research

by Christopher G. Sinon, PhD and Stella M. Papa, MD

COVID-19, Anxiety, and Parkinson's: Staying Healthy in These Unusual Times

by Elizabeth "Eli" Pollard

Comprehensive LivingEli PollardMarch 23, 2020Parkinson, COVID-19, anxiety, virus, four, corona virusComment

Onsens and Other Kyoto Musings

by Binit B. Shah MD

Clinical ScienceBinit B. Shah MDMarch 16, 2020World Parkinson Congress, Kyoto, fourComment

Can we use drugs that Modulate the Renin-Angiotensin system to treat Parkinson's disease?

by Santiago Perez Lloret, MD, PhD, Matilde Otero-Losada, PhD, Lucas Udovin, PhD Francisco Capani, MD, PhD

Going against the Grain

by Suketu M. Khandhar, MD

Clinical ScienceSuketu M. Khandhar, MDFebruary 10, 2020Parkinson, fourComment

Why dyskinesias are a research priority in PD

by M. Angela Cenci Nilsson, MD, PhD

Clinical ScienceAngela Cenci NilssonFebruary 3, 2020research, Dyskinesia, fourComment